PharmaSGP Holding Investor Relations Material
Latest events
Q1 2025
28 May, 2025
Q4 2024
15 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from PharmaSGP Holding SE
Access all reports
PharmaSGP Holding SE is a health technology company that specializes in the development, sale, and marketing of non-prescription (over-the-counter) drugs, chemical-free painkillers, and herbal medicines. Established in 2012 and headquartered in Gräefelfing, Germany, the company offers a broad range of healthcare products targeting various medical conditions without the use of chemical substances. Its portfolio includes well-known brands such as Baldriparan, Formigran, Spalt, Kamol, RubaXX, Restaxil, DESEO, and NERADIN, each designed to address specific health concerns like sleep disorders, pain relief, rheumatic pain, and sexual health, among others. Its shares are listed on the XETRA.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
PSG
Country
🇩🇪 Germany